Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
18.98
+0.90 (4.98%)
Oct 14, 2025, 3:23 PM EDT - Market open
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $509.00 million as of October 14, 2025. Its market cap has increased by 246.85% in one year.
Market Cap
509.00M
Enterprise Value
490.18M
1-Year Change
246.85%
Ranking
Category
Stock Price
$18.98
Market Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $509.00M, an increase of 381.37%. That is a compound annual growth rate of 25.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 484.86M | 36.67% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | 196.86M | 53.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 745.22B |
| Johnson & Johnson | 458.52B |
| AbbVie | 411.52B |
| UnitedHealth Group | 324.73B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.16B |